alpha-aminopyridine has been researched along with Dermatitis, Atopic in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berk, D; Bhatia, N; Bissonnette, R; Draelos, Z; Droege, M; Eads, K; Elias, M; Ferris, L; Gooderham, M; Guenthner, S; Higham, R; Jones, T; Kempers, S; Kircik, L; Koppel, R; Lee, M; Merritt, C; Navale, L; Saint-Cyr Proulx, E; Welgus, H; Zirwas, M | 1 |
| Chat, VS; Kearns, DG; Uppal, SK; Wu, JJ | 1 |
| Savall, BM; Thurmond, RL; Tichenor, MS; Venable, JD | 1 |
| Cheon, HG; Cho, YS; Heo, JY | 1 |
| Burnet, M; Guse, JH; Gutke, HJ; Khobzaoui, M; Renukappa-Gutke, T | 1 |
3 review(s) available for alpha-aminopyridine and Dermatitis, Atopic
| Article | Year |
|---|---|
Topical Agents Currently in Phase II or Phase III Trials for Atopic Dermatitis.
Topics: Administration, Cutaneous; Aminopyridines; Benzamides; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclopropanes; Dermatitis, Atopic; Dermatologic Agents; Humans; Nitriles; Pyrazoles; Pyrimidines; Resorcinols; Severity of Illness Index; Skin Cream; Stilbenes; Treatment Outcome | 2020 |
Functional Profiling of 2-Aminopyrimidine Histamine H4 Receptor Modulators.
Topics: Aminopyridines; Animals; Arthritis, Rheumatoid; Asthma; Dermatitis, Atopic; Drug Partial Agonism; Histamine Agonists; Histamine Antagonists; Humans; Hypersensitivity; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Structure-Activity Relationship | 2015 |
AWD-12-281 (inhaled) (elbion/GlaxoSmithKline).
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Inhalation; Administration, Topical; Amides; Aminopyridines; Animals; Benzamides; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Dermatitis, Atopic; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Indoles; Inflammation; Lipopolysaccharides; Ovalbumin; Phosphodiesterase Inhibitors; Psoriasis; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Diseases; Structure-Activity Relationship | 2005 |
1 trial(s) available for alpha-aminopyridine and Dermatitis, Atopic
| Article | Year |
|---|---|
The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients With Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept Study.
Topics: Aminopyridines; Benzamides; Dermatitis, Atopic; Double-Blind Method; Emollients; Humans; Proof of Concept Study; Severity of Illness Index; Treatment Outcome | 2023 |
1 other study(ies) available for alpha-aminopyridine and Dermatitis, Atopic
| Article | Year |
|---|---|
Topical effects of roflumilast on 1-chloro-2,4-dinitrobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice.
Topics: Aminopyridines; Animals; Benzamides; Body Weight; Cell Line; Cell Proliferation; Cyclic AMP; Cyclopropanes; Dermatitis, Atopic; Dinitrochlorobenzene; Down-Regulation; Female; Humans; Immunoglobulin E; Interleukin-1alpha; Irritants; Local Lymph Node Assay; Lymph Nodes; Mice; Mice, Inbred BALB C; Phosphodiesterase 4 Inhibitors; Skin; Th1 Cells | 2010 |